Personalis (PSNL) Net Income towards Common Stockholders (2018 - 2026)
Personalis (PSNL) posted quarterly Net Income towards Common Stockholders of -$30.0 million for Q1 2026, down 90.68% year-over-year from -$322.2 million in Q1 2025, and down 25.9% quarter-over-quarter from -$23.9 million in Q4 2025.
Personalis (PSNL) Net Income towards Common Stockholders (2018 - 2026) Analysis & Trends
Personalis' Net Income towards Common Stockholders history runs 9 years deep, the most recent figure standing at -$30.0 million for Q1 2026.
- In Q1 2026, Net Income towards Common Stockholders fell 90.68% year-over-year to -$30.0 million; the TTM figure through Mar 2026 stood at -$95.6 million (down 42.72% YoY), while the FY2025 annual figure was -$81.3 million, down 26.65% from the prior year.
- Net Income towards Common Stockholders for Q1 2026 stood at -$30.0 million, down from -$23.9 million in the prior quarter.
- The five-year high for Net Income towards Common Stockholders was $80.3 million in Q4 2023, with the low at -$39.1 million in Q3 2024.
- The 5-year median for Net Income towards Common Stockholders is -$24.0 million (2023), against an average of -$17.1 million.
- The sharpest annual moves came in 2023 and 2025: Net Income towards Common Stockholders surged 358.22% in 2023, then plunged 3719.73% in 2025.
- Personalis' Net Income towards Common Stockholders stood at -$31.1 million in 2022, then jumped by 358.22% to $80.3 million in 2023, then tumbled by 99.18% to $659000.0 in 2024, then slumped by 3719.73% to -$23.9 million in 2025, then slipped by 25.9% to -$30.0 million in 2026.
- Business Quant data shows PSNL's Net Income towards Common Stockholders at -$30.0 million in Q1 2026, -$23.9 million in Q4 2025, and -$21.7 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.44 Bn | 209.37 Bn | 8.34 Bn | 1.76 Bn |
| 2 | Danaher | 139.95 Bn | 135.60 Bn | 3.61 Bn | 870.00 Mn |
| 3 | Idexx Laboratories | 46.16 Bn | 45.96 Bn | 779.09 Mn | 338.41 Mn |
| 4 | Agilent Technologies | 39.67 Bn | 37.87 Bn | 990.00 Mn | 339.00 Mn |
| 5 | Iqvia Holdings | 39.29 Bn | 37.21 Bn | 1.44 Bn | 241.00 Mn |
| 6 | Natera | 38.61 Bn | 37.51 Bn | 696.04 Mn | -85.11 Mn |
| 7 | Illumina | 29.99 Bn | 28.82 Bn | 770.00 Mn | 207.00 Mn |
| 8 | Mettler Toledo International | 28.57 Bn | 28.51 Bn | 650.22 Mn | 232.90 Mn |
| 9 | Quest Diagnostics | 26.17 Bn | 25.55 Bn | 1.03 Bn | 324.00 Mn |
| 10 | Personalis | 1.41 Bn | 1.18 Bn | 281,000.00 | -30.03 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -30.03 Mn |
| Dec 31, 2025 | -23.85 Mn |
| Sep 30, 2025 | -21.65 Mn |
| Jun 30, 2025 | -20.06 Mn |
| Mar 31, 2025 | -15.75 Mn |
| Dec 31, 2024 | 659,000.00 |
| Sep 30, 2024 | -39.09 Mn |
| Jun 30, 2024 | -12.80 Mn |
| Mar 31, 2024 | -12.97 Mn |
| Dec 31, 2023 | 80.30 Mn |
| Sep 30, 2023 | -29.10 Mn |
| Jun 30, 2023 | -23.96 Mn |
| Mar 31, 2023 | -28.66 Mn |
| Dec 31, 2022 | -31.10 Mn |
| Sep 30, 2022 | -26.49 Mn |
| Jun 30, 2022 | -27.55 Mn |
| Mar 31, 2022 | -28.21 Mn |
| Dec 31, 2021 | 45.22 Mn |
| Sep 30, 2021 | -17.67 Mn |
| Jun 30, 2021 | -14.95 Mn |